NovoCure Ltd — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Brackmann Christoph | Chief Financial Officer | Tax Withholding | 7,033 | $12.23 | $86,014 | 134,117 | Nov 4, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Tax Withholding | 2,949 | $12.23 | $36,066 | 80,439 | Nov 1, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Tax Withholding | 966 | $12.81 | $12,374 | 347,745 | Nov 1, 2025 |
| Puri Michal Nath | Chief Human Resources Officer | Tax Withholding | 752 | $12.82 | $9,641 | 163,762 | Oct 31, 2025 |
| Cordova Ashley | Chief Executive Officer | Purchase | 81,550 | $12.22 | $996,541 | 437,569 | Sep 5, 2025 |
| Brackmann Christoph | Chief Financial Officer | Purchase | 5,000 | $11.60 | $58,000 | 136,150 | Jul 29, 2025 |
| Puri Michal Nath | Chief Human Resources Officer | Award / Grant | 833 | $15.13 | $12,603 | 164,514 | Jun 30, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Award / Grant | 833 | $15.13 | $12,603 | 348,711 | Jun 30, 2025 |
| Danziger Asaf | — | Award / Grant | 833 | $15.13 | $12,603 | 416,473 | Jun 30, 2025 |
| Cordova Ashley | Chief Executive Officer | Award / Grant | 833 | $15.13 | $12,603 | 356,019 | Jun 30, 2025 |
| Ben Arye Barak | General Counsel | Award / Grant | 769 | $15.13 | $11,635 | 174,465 | Jun 30, 2025 |
| LEUNG GABRIEL | — | Award / Grant | 11,215 | — | — | 92,444 | Jun 4, 2025 |
| Stafford Kristin | — | Award / Grant | 11,215 | — | — | 14,269 | Jun 4, 2025 |
| HILLEMAN JERYL L | — | Award / Grant | 11,215 | — | — | 16,806 | Jun 4, 2025 |
| Ocean Allyson J | — | Award / Grant | 11,215 | — | — | 14,269 | Jun 4, 2025 |
| Scannell Timothy J | — | Award / Grant | 11,215 | — | — | 17,233 | Jun 4, 2025 |
| Hung David | — | Award / Grant | 11,215 | — | — | 23,410 | Jun 4, 2025 |
| VERNON W ANTHONY | — | Award / Grant | 11,215 | — | — | 179,102 | Jun 4, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Award / Grant | 179,426 | — | — | 347,878 | Jun 4, 2025 |
| Stafford Kristin | — | Sale | 999 | $17.28 | $17,263 | 3,054 | Jun 3, 2025 |
| LEUNG GABRIEL | — | Sale | 999 | $17.31 | $17,293 | 81,229 | Jun 3, 2025 |
| Madden Martin J. | — | Sale | 999 | $17.19 | $17,173 | 18,674 | Jun 3, 2025 |
| Scannell Timothy J | — | Sale | 999 | $17.32 | $17,303 | 6,018 | Jun 3, 2025 |
| HILLEMAN JERYL L | — | Sale | 999 | $17.26 | $17,243 | 5,591 | Jun 3, 2025 |
| Ocean Allyson J | — | Sale | 999 | $17.29 | $17,273 | 3,054 | Jun 3, 2025 |
| VERNON W ANTHONY | — | Sale | 999 | $17.35 | $17,333 | 167,887 | Jun 3, 2025 |
| Hung David | — | Sale | 999 | $17.30 | $17,283 | 12,195 | Jun 3, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 1,879 | $19.01 | $35,720 | 168,452 | Jun 2, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 592 | $17.91 | $10,603 | 83,556 | May 3, 2025 |
| Brackmann Christoph | Chief Financial Officer | Award / Grant | 54,975 | $18.19 | $999,995 | 121,150 | Mar 4, 2025 |
| Leupin Nicolas | Chief Medical Officer | Award / Grant | 54,975 | $18.19 | $999,995 | 105,108 | Mar 4, 2025 |
| Ben Arye Barak | General Counsel | Award / Grant | 54,975 | $18.19 | $999,995 | 173,696 | Mar 4, 2025 |
| Puri Michal Nath | Chief Human Resources Officer | Award / Grant | 54,975 | $18.19 | $999,995 | 163,681 | Mar 4, 2025 |
| Weinberg Uri | Chief Innovation Officer | Award / Grant | 54,975 | $18.19 | $999,995 | 221,218 | Mar 4, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Award / Grant | 54,975 | $18.19 | $999,995 | 198,648 | Mar 4, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Award / Grant | 54,975 | $18.19 | $999,995 | 84,148 | Mar 4, 2025 |
| Cordova Ashley | Chief Executive Officer | Award / Grant | 151,181 | $18.19 | $2,749,982 | 355,186 | Mar 4, 2025 |
| Weinberg Uri | Chief Innovation Officer | Sale | 268 | $18.92 | $5,071 | 166,243 | Mar 3, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 2,527 | $18.54 | $46,851 | 143,673 | Mar 3, 2025 |
| Cordova Ashley | Chief Executive Officer | Sale | 2,053 | $18.54 | $38,063 | 204,005 | Mar 3, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 250 | $18.54 | $4,635 | 29,173 | Mar 3, 2025 |
| Weinberg Uri | Chief Innovation Officer | Sale | 4,326 | $18.78 | $81,242 | 166,822 | Feb 28, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 267 | $20.55 | $5,487 | 29,791 | Feb 28, 2025 |
| Weinberg Uri | Chief Innovation Officer | Sale | 4,326 | $18.78 | $81,242 | 166,822 | Feb 28, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 1,989 | $20.55 | $40,874 | 148,970 | Feb 28, 2025 |
| Cordova Ashley | Chief Executive Officer | Sale | 9,345 | $19.92 | $186,152 | 210,207 | Feb 28, 2025 |
| Paravasthu Mukund | Chief Operating Officer | Sale | 1,379 | $19.92 | $27,470 | 30,058 | Feb 28, 2025 |
| Cordova Ashley | Chief Executive Officer | Sale | 2,341 | $18.28 | $42,793 | 206,058 | Feb 27, 2025 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | Sale | 1,989 | $20.55 | $40,874 | 148,970 | Feb 27, 2025 |
| Puri Michal Nath | Chief Human Resources Officer | Sale | 1,162 | $19.92 | $23,147 | 108,931 | Feb 27, 2025 |